company background image
5245

Kilitch Drugs (India) BSE:524500 Stock Report

Last Price

₹169.35

Market Cap

₹2.7b

7D

7.2%

1Y

-14.2%

Updated

14 Aug, 2022

Data

Company Financials
524500 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends0/6

524500 Stock Overview

Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India.

Kilitch Drugs (India) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kilitch Drugs (India)
Historical stock prices
Current Share Price₹169.35
52 Week High₹276.40
52 Week Low₹144.30
Beta0.53
1 Month Change3.90%
3 Month Change4.67%
1 Year Change-14.23%
3 Year Change57.61%
5 Year Change228.83%
Change since IPO7,106.38%

Recent News & Updates

Shareholder Returns

524500IN PharmaceuticalsIN Market
7D7.2%-0.4%1.3%
1Y-14.2%-12.8%8.1%

Return vs Industry: 524500 underperformed the Indian Pharmaceuticals industry which returned -12.8% over the past year.

Return vs Market: 524500 underperformed the Indian Market which returned 8.1% over the past year.

Price Volatility

Is 524500's price volatile compared to industry and market?
524500 volatility
524500 Average Weekly Movement7.7%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 524500 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 524500's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1978123Mukund Mehtahttps://www.kilitch.com

Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products.

Kilitch Drugs (India) Limited Fundamentals Summary

How do Kilitch Drugs (India)'s earnings and revenue compare to its market cap?
524500 fundamental statistics
Market Cap₹2.72b
Earnings (TTM)₹82.66m
Revenue (TTM)₹1.28b

32.9x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
524500 income statement (TTM)
Revenue₹1.28b
Cost of Revenue₹746.03m
Gross Profit₹533.77m
Other Expenses₹451.11m
Earnings₹82.66m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)5.14
Gross Margin41.71%
Net Profit Margin6.46%
Debt/Equity Ratio14.6%

How did 524500 perform over the long term?

See historical performance and comparison